10% Owner · Artiva Biotherapeutics, Inc. · Common Stock
Side
BUY
Value
$4.00M
Shares
347.2K
Price
$11.52
Executed
May 11, 2026
Disclosed
May 28, 2026
Disclosure timeline17 days from execution to publication · legal deadline 2 business days
May 11 executedMay 28, 2026 disclosed
ARTV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 13 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
GC Corp. filed this Form 4 reporting a open-market purchase of ARTV on May 11, 2026. It became public on May 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
10% Owner
GC Corp.cik:0001931382
Issuer
Artiva Biotherapeutics, Inc.cik:0001817241
Revision history · 0
No field has changed since this record was first ingested.
